MDLH — Medical International Technology Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.01m
- -$0.08m
- $0.54m
Annual income statement for Medical International Technology, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2011 September 30th | 2012 September 30th | 2013 September 30th | 2014 September 30th | 2015 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.437 | 0.996 | 0.847 | 0.425 | 0.545 |
Cost of Revenue | |||||
Gross Profit | 0.237 | 0.737 | 0.633 | 0.337 | 0.252 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 0.903 | 0.969 | 0.777 | 0.494 | 0.587 |
Operating Profit | -0.466 | 0.027 | 0.07 | -0.068 | -0.043 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.643 | -0.11 | 0.983 | -0.08 | -0.061 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.643 | -0.11 | 0.983 | -0.08 | -0.061 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.643 | -0.11 | 0.983 | -0.08 | -0.061 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.643 | -0.11 | 0.983 | -0.08 | -0.061 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.009 | -0.001 | 0.012 | -0.001 | -0.001 |
Dividends per Share |